Stimuli-Responsive Delivery Systems for Intervertebral Disc Degeneration
Jianing Tang,Yuexin Luo,Qirui Wang,Juntao Wu,Yulong Wei
DOI: https://doi.org/10.2147/ijn.s463939
IF: 7.033
2024-05-25
International Journal of Nanomedicine
Abstract:Jianing Tang, 1, 2, &ast Yuexin Luo, 1, 2, &ast Qirui Wang, 1, 2 Juntao Wu, 1, 2 Yulong Wei 1 1 Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 First Clinic School, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yulong Wei, Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, People's Republic of China, Email As a major cause of low back pain, intervertebral disc degeneration is an increasingly prevalent chronic disease worldwide that leads to huge annual financial losses. The intervertebral disc consists of the inner nucleus pulposus, outer annulus fibrosus, and sandwiched cartilage endplates. All these factors collectively participate in maintaining the structure and physiological functions of the disc. During the unavoidable degeneration stage, the degenerated discs are surrounded by a harsh microenvironment characterized by acidic, oxidative, inflammatory, and chaotic cytokine expression. Loss of stem cell markers, imbalance of the extracellular matrix, increase in inflammation, sensory hyperinnervation, and vascularization have been considered as the reasons for the progression of intervertebral disc degeneration. The current treatment approaches include conservative therapy and surgery, both of which have drawbacks. Novel stimuli-responsive delivery systems are more promising future therapeutic options than traditional treatments. By combining bioactive agents with specially designed hydrogels, scaffolds, microspheres, and nanoparticles, novel stimuli-responsive delivery systems can realize the targeted and sustained release of drugs, which can both reduce systematic adverse effects and maximize therapeutic efficacy. Trigger factors are categorized into internal (pH, reactive oxygen species, enzymes, etc.) and external stimuli (photo, ultrasound, magnetic, etc.) based on their intrinsic properties. This review systematically summarizes novel stimuli-responsive delivery systems for intervertebral disc degeneration, shedding new light on intervertebral disc therapy. Keywords: stimulus response, delivery system, intervertebral disc degeneration, biomaterial Intervertebral disc (IVD) degeneration (IVDD) is a major cause (40%) of low back pain (LBP), with a prevalence of over 11.9% in the population worldwide (over 568 million), which leads to huge economic losses estimated at 70 billion euros annually. 1–4 Epidemiological research in 195 countries found that LBP is the primary cause of years lived with disability in 126 countries. 5 As an essential structure in the human body, the intervertebral disc allows correct spatial alignment of vertebrae and facet joints, provides spinal mechanical stability, and enables segment movement. 6 The intervertebral disc comprises the nucleus pulposus (NP), annulus fibrosus (AF), and cartilage endplates (CEP). All these factors collectively participate in maintaining the structure and physiological functions of the disc. The pathology of IVDD mainly includes dysfunction of intervertebral disc cells and an imbalance between anabolism and catabolism of the extracellular matrix (ECM). 7–10 Current IVDD treatments can be classified into conservative therapy (physical exercise and therapy, oral medication, and pain-relieving injections) and surgery. 11 Surgical treatments include intervertebral disc fusion (regarded as the standard method) and total disc replacement. 11 However, these IVDD treatment categories have unavoidable disadvantages. It is often difficult to achieve effective therapeutic outcomes with conservative physical treatments. 12 Moreover, owing to the avascular nature of the IVDs, it is difficult to achieve therapeutic concentrations of bioactive agents by systemic administration. The high doses of drugs required may cause multiple systemic side effects. Although local injections and interventional treatment can avoid this dilemma, repeated injections can cause adverse effects. 13 Simultaneously, the degenerated intervertebral disc features a harsh microenvironment, including acidic, oxidative, inflammatory, and chaotic cytokines, which is not conducive to medication. 14 However, surgical treatment is expensive, risky, and relapsable. IVD fusion eliminates the movement of the adjacent vertebral body, while total disc replacement induces a series of complications, including facet di -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology